Gene: MYCN
Official Full Name: MYCN proto-oncogene, bHLH transcription factorprovided by HGNC
Gene Summary: This gene is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. This protein is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. Amplification of this gene is associated with a variety of tumors, most notably neuroblastomas. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA14708 | MYCN Knockout cell line (AC16) | Human | MYCN | 1:3-1:4 | negative | Online Inquiry |
| KOA30151 | MYCN Knockout cell line (BEAS-2B) | Human | MYCN | 1:3~1:4 | negative | Online Inquiry |
| KOA45578 | MYCN Knockout cell line (U-2932) | Human | MYCN | 1:2-1:4 | negative | Online Inquiry |
| KOA60961 | MYCN Knockout cell line (TPC-1) | Human | MYCN | 1:5-1:8 | negative | Online Inquiry |
| KOA76389 | MYCN Knockout cell line (NCM460) | Human | MYCN | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.